Daniela J Conrado - e‐Quantify LLC

基本信息

Career Trajectory

Bio

Dr. Daniela Conrado has over 10 years of research experience in pre-clinical or clinical pharmacology and pharmacometrics. She has worked on Phase 1 through Phase 4 stages supporting model-informed drug discovery and development (MID3) activities. Her current focus is on advancing quantitative drug development tools for neurodegenerative diseases.

Research Interests

Papers共 76 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluation of pharmacokinetics (pk), serum cytokines, and safety following intravenous (iv) or subcutaneous (sc) step-up dosing of ubamatamab, a muc16xcd3 bispecific antibody, in patients with recurrent ovarian cancer (oc)

P. Madia,D. Conrado,J. Brouwer-Visser, Q. Qin, J. Davis,T. Uldrick,M. Peterman, E. Miller, M. Zhu

CLINICAL PHARMACOLOGY & THERAPEUTICS (2024): S65-S65

Cited0Views0Bibtex

Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development

John D. Davis, Marcal Bravo Padros,Daniela J. Conrado,Samit Ganguly, Xiaowen Guan,Hazem E. Hassan,Anasuya Hazra,Susan C. Irvin,Priya Jayachandran,Matthew P. Kosloski,Kuan-Ju Lin,Kamalika Mukherjee,Anne Paccaly,Apostolos Papachristos,Michael A. Partridge,Saileta Prabhu,Jennifer Visich, Erik S. Welf, Xiaoying Xu,An Zhao, Min Zhu

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 3 (2024): 422-439

Cited0Views0WOSBibtex

Odronextamab Monotherapy for the Treatment of Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Focus on Clinical Pharmacology and Pharmacometrics in the ELM-1 and ELM-2 Studies

Min Zhu,Daniela J. Conrado,Kamal Srinivasan,Jurriaan Brouwer‐Visser,Hong Yan, Hesham Mohamed,Aafia Chaudhry,Srikanth R. Ambati,Lutz Harnisch,John D. Davis

Bloodno. Supplement 1 (2023): 1436-1436

Cited0Views0Bibtex

Min Zhu,Daniela Conrado,Kamal Srinivasan,Jurriaan Brouwer-Visser, Hong Yan,Hesham Mohamed,Aafia Chaudhry,Srikanth Ambati,Lutz Harnisch,John D Davis

Bloodno. Supplement 1 (2023): 1436-1436

Cited0Views0Bibtex

Translational findings from the ongoing first-in-human (fih) study of ubamatamab (regn4018, muc16xcd3 bispecific antibody [bsab]) in patients (pts) with recurrent ovarian cancer (oc): regimen selection

M. Zhu, A. Crawford, M. Retter, M. Khaksar Toroghi,D. Conrado,J. Brouwer-Visser, P. Krueger, X. Meng, J. Davis,M. Peterman,T. Uldrick, E. Miller

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023): S59-S59

Cited0Views0Bibtex

Population Pharmacokinetics Modeling and Exposure‐response Analyses of Cemiplimab in Patients with Recurrent or Metastatic Cervical Cancer

Jenny-Hoa Nguyen,Daniel Epling,Nancy Dolphin,Anne Paccaly,Daniela Conrado,John D. Davis,Nidal Al-Huniti

CPT pharmacometrics & systems pharmacologyno. 11 (2022): 1458-1471

Cited1Views0WOSBibtex

Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV-2

Mohamed A. Kamal,Andreas Kuznik,Luyuan Qi,Witold Wiecek,Mohamed Hussein,Hazem E. Hassan,Kashyap Patel,Thomas Obadia,Masood Khaksar Toroghi,Daniela J. Conrado,Nidal Al-Huniti,Roman Casciano,Meagan P. O'Brien,Ruanne Barnabas,Myron S. Cohen,Patrick F. Smith

Clinical pharmacology and therapeuticsno. 6 (2022): 1224-1235

Cited0Views0WOSBibtex

Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy

Karthik Lingineni,Varun Aggarwal,Juan Francisco Morales,Daniela J. Conrado,Diane Corey,Camille Vong,Jackson Burton,Jane Larkindale,Klaus Romero,Stephan Schmidt,Sarah Kim

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY（2022）

Cited10Views0WOSBibtex

Monoclonal Antibody Treatment, Prophylaxis and Vaccines Combined to Reduce SARS CoV-2 Spread

Mohamed A. Kamal,Andreas Kuznik,Luyuan Qi,Witold Więcek,Mohamed Hussein,Hazem E. Hassan,Kashyap Patel,Thomas Obadia,Masood Khaksar Toroghi,Daniela J. Conrado,Nidal Al-Huniti,Roman Casciano,Meagan P. O’Brien,Ruanne V. Barnabas,Myron S. Cohen,Patrick F. Smith

medRxiv (Cold Spring Harbor Laboratory) (2021)

Cited1Views0Bibtex

Monoclonal Antibodies to Reduce SARS CoV-2 Transmission and Mortality

Mohamed Kamal,Andreas Kuznik,Qi Liu,Witold Więcek,Mohamed Hussein,Hazem E. Hassan,Kashyap Patel,Thomas Obadia,Masood Khaksar Toroghi,Daniela J. Conrado,Nidal Al‐Huniti,Roman Casciano,Meagan P. O’Brien,Ruanne V. Barnabas,Myron S. Cohen,Patrick F. Smith

Zenodo (CERN European Organization for Nuclear Research) (2021)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn